Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
12,15 USD | +0,50% |
|
+9,56% | +41,28% |
Attività
Numero di dipendenti: 28
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 01/11/20 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 01/03/22 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
David Rodman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/21 |
Minji Kim
PRN | Corporate Officer/Principal | - | 04/01 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 56 | 01/02/21 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 13/09/23 |
Daphne Karydas
BRD | Director/Board Member | 49 | 13/09/23 |
Jon Congleton
CEO | Chief Executive Officer | 60 | 01/11/20 |
Derek DiRocco
BRD | Director/Board Member | 43 | 08/05/22 |
BT Slingsby
FOU | Founder | 47 | 31/05/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 49 648 540 | 43 487 795 ( 87,59 %) | 0 | 87,59 % |
Coordinate società
Mineralys Therapeutics, Inc.
150 North Radnor Chester Road Suite F200
19087, Radnor
+
http://www.mineralystx.com![Indirizzo Mineralys Therapeutics, Inc.(MLYS)](https://cdn.zonebourse.com/static/address/150491009.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+41,28% | 603 Mln | |
+16,59% | 44,44 Mrd | |
+42,32% | 39,84 Mrd | |
-10,62% | 37,68 Mrd | |
+29,92% | 31,46 Mrd | |
-9,78% | 27,02 Mrd | |
+12,34% | 26,29 Mrd | |
+41,53% | 13,8 Mrd | |
+31,49% | 12,46 Mrd | |
-7,40% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione MLYS
- Società Mineralys Therapeutics, Inc.